Key Documents

COA/COQ

MAB1921P

Anti-Laminin beta 1 (LAMB1) Antibody

Name: Anti-Laminin beta 1 (LAMB1) Antibody
Brand: MM

CHEMICON^®, mouse monoclonal, 4E10

Synonym(s):

Laminin B1 Chain

Sign Into View Organizational & Contract Pricing

Select a Size

All Photos(1)

About This Item

UNSPSC Code:

12352203

eCl@ss:

32160702

NACRES:

NA.41

Product Name

Anti-Laminin β1 Antibody, clone 4E10, clone 4E10, Chemicon^®, from mouse

biological source

mouse

Quality Level

100

antibody form

purified immunoglobulin

antibody product type

primary antibodies

clone

4E10, monoclonal

species reactivity

human

manufacturer/tradename

Chemicon^®

technique(s)

ELISA: suitable
immunofluorescence: suitable
immunoprecipitation (IP): suitable
western blot: suitable

isotype

IgG1κ

NCBI accession no.

NM_002291.1

UniProt accession no.

P07942

shipped in

wet ice

target post-translational modification

unmodified

Gene Information

human ... LAMB1(3912)

Immunogen

Purified human laminin

Application

Detect Laminin β1 using this Anti-Laminin β1 Antibody, clone 4E10 validated for use in ELISA, IF, IP & WB.

Research Category
Cell Structure

Research Sub Category
ECM Proteins

Western blot

Immunoprecipitation

Immunoflurescence

ELISA

Immunoaffinity chromatography

Optimal working dilutions must be determined by the end user.

Biochem/physiol Actions

Reacts with the beta1 chain of intact laminin and blocks the neurite stimulating activity of human laminin. No cross-reactivity with mouse laminin.

Physical form

Format: Purified

Purified immunoglobulin. Liquid in PBS, pH 7.6, containing 0.1% sodium azide.

Preparation Note

Maintain at 2°-8°C for up to 12 months from date of receipt.

Other Notes

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?

Try our Product Selector Tool.

Storage Class Code

10 - Combustible liquids

WGK

WGK 2

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Reinvestigating Tumor-Ventricle Relationship of Craniopharyngiomas With Predominantly Ventricular Involvement: An Endoscopic Endonasal Series Based on Histopathological Assessment.

Jun Fan et al.

Frontiers in oncology, 11, 740410-740410 (2021-12-21)

Craniopharyngiomas (CPs) predominantly involving the third ventricle were commonly termed "intraventricular" lesions. The aim of this study was to clarify the anatomical relationship between the tumor and the third ventricle by both surgical and histological investigation. A retrospective review of

iMyoblasts for ex vivo and in vivo investigations of human myogenesis and disease modeling.

Dongsheng Guo et al.

eLife, 11 (2022-01-26)

Skeletal muscle myoblasts (iMyoblasts) were generated from human induced pluripotent stem cells (iPSCs) using an efficient and reliable transgene-free induction and stem cell selection protocol. Immunofluorescence, flow cytometry, qPCR, digital RNA expression profiling, and scRNA-Seq studies identify iMyoblasts as a

Utility of Immunohistochemistry and Western Blot in Profiling Clinically Suspected Cases of Congenital Muscular Dystrophy.

Radhika Mhatre et al.

Annals of Indian Academy of Neurology, 24(2), 198-203 (2021-07-06)

Immunocharacterization of congenital muscular dystrophy (CMD) to determine the frequency of various subtypes in a large Indian Cohort. This retrospective (2014-2017) study was carried on muscle biopsies of clinically suspected cases of CMD with histological evidence of dystrophy/myopathic features. Immunohistochemistry

Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrix formation.

Amber N Stratman et al.

Blood, 114(24), 5091-5101 (2009-10-14)

We show that endothelial cell (EC)-generated vascular guidance tunnels (ie, matrix spaces created during tube formation) serve as conduits for the recruitment and motility of pericytes along EC ablumenal surfaces to facilitate vessel maturation events, including vascular basement membrane matrix

Global Trade Item Number

SKU	GTIN
MAB1921P	04053252664885

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service